Patents by Inventor Kjesten A. Wiig

Kjesten A. Wiig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Treating Alzheimer's Disease
    Publication number: 20140194524
    Abstract: Cognitive impairments in humans with Alzheimer's disease are treated by administering a composition that includes an amphetamine compound. Memory, attention and executive function can be improved following administration of the amphetamine compound.
    Type: Application
    Filed: December 13, 2013
    Publication date: July 10, 2014
    Applicant: Cognition Pharmaceuticals, LLC
    Inventors: Mel H. Epstein, Kjesten A. Wiig, Mark F. Bear
  • METHODS FOR TREATING ALZHEIMER'S DISEASE
    Publication number: 20130231395
    Abstract: Cognitive impairments in humans with Alzheimer's disease are treated by administering a composition that includes an amphetamine compound. Memory, attention and executive function can be improved following administration of the amphetamine compound.
    Type: Application
    Filed: April 18, 2013
    Publication date: September 5, 2013
    Applicant: Cognition Pharmaceuticals, LLC
    Inventors: Mel H. Epstein, Kjesten A. Wiig, Mark F. Bear
  • METHODS FOR TREATING ALZHEIMER'S DISEASE
    Publication number: 20120142785
    Abstract: Alzheimer's disease is treated with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.
    Type: Application
    Filed: January 10, 2012
    Publication date: June 7, 2012
    Applicant: Cognition Pharmaceuticals LLC
    Inventors: Mel H. Epstein, Kjesten A. Wiig, Mark F. Bear
  • Methods for treating cognitive impairment in humans
    Publication number: 20100022658
    Abstract: Cognitive impairments in humans with multiple sclerosis are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.
    Type: Application
    Filed: August 6, 2008
    Publication date: January 28, 2010
    Applicant: Cognition Pharmaceuticals LLC
    Inventors: Mel H. Epstein, Kjesten A. Wiig
  • Methods for treating mild cognitive impairment and alzheimer's disease
    Publication number: 20100010097
    Abstract: Mild cognitive impairment and Alzheimer's disease are treated with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.
    Type: Application
    Filed: October 31, 2008
    Publication date: January 14, 2010
    Applicant: Cognition Pharmaceuticals, LLC
    Inventors: Mel H. Epstein, Kjesten A. Wiig, Jeroen Verheijen
  • Methods for treating cognitive impairment in humans with Multiple Sclerosis
    Patent number: 7619005
    Abstract: Cognitive impairments in humans with multiple sclerosis are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: November 17, 2009
    Assignee: Cognition Pharmaceuticals LLC
    Inventors: Mel H. Epstein, Kjesten A. Wiig, Randall L. Carpenter
  • Methods of treating memory and cognitive impairments in humans following stroke and traumatic brain injury
    Publication number: 20070197663
    Abstract: Cognitive impairments are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.
    Type: Application
    Filed: December 8, 2006
    Publication date: August 23, 2007
    Inventors: Mel Epstein, Kjesten Wiig
  • Methods for treating an impairment in memory consolidation
    Patent number: 7244769
    Abstract: Impairments in memory consolidation are treated with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound. The method can include determining memory consolidation before, during and/or after administering the amphetamine compound.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: July 17, 2007
    Assignee: Cognition Pharmaceuticals, LLC
    Inventors: Mel H. Epstein, Kjesten A. Wiig
  • Methods for treating coginitive impairment and improving cognition
    Publication number: 20070117869
    Abstract: Cognitive impairments are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an I-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.
    Type: Application
    Filed: May 21, 2004
    Publication date: May 24, 2007
    Inventors: Mel Epstein, Kjesten Wiig, Randall Carpenter, Peter Zarevics, H. Moore Arnold
  • Methods and compositions for regulating memory consolidation
    Publication number: 20060167112
    Abstract: The present invention makes available methods and reagents for enhancing and/or restoring long-term memory function and performance.
    Type: Application
    Filed: December 15, 2005
    Publication date: July 27, 2006
    Inventors: Mel Epstein, Kjesten Wiig
  • Methods for treating an impairment in memory consolidation
    Publication number: 20060167111
    Abstract: Impairments in memory consolidation are treated with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound. The method can include determining memory consolidation before, during and/or after administering the amphetamine compound.
    Type: Application
    Filed: December 15, 2005
    Publication date: July 27, 2006
    Inventors: Mel Epstein, Kjesten Wiig
  • Methods for treating cognitive impairment in humans with multiple sclerosis
    Publication number: 20060111448
    Abstract: Cognitive impairments in humans with multiple sclerosis are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.
    Type: Application
    Filed: May 19, 2005
    Publication date: May 25, 2006
    Inventors: Mel Epstein, Kjesten Wiig, Randall Carpenter
  • Methods for treating mild cognitive impairment and alzheimer's disease
    Publication number: 20050059743
    Abstract: Mild cognitive impairment and Alzheimer's disease are treated with an amphetamine compound. In one embodiment, the method includes administering an 1-amphetamine compound. In another embodiment, the method includes administering an 1-methamphetamine compound.
    Type: Application
    Filed: March 2, 2004
    Publication date: March 17, 2005
    Applicant: Sention, Inc.
    Inventors: Mel Epstein, Kjesten Wiig, Jeroen Verheijen
  • Methods and compositions for regulating memory consolidation
    Patent number: 6828351
    Abstract: The present invention makes available methods and reagents for enhancing and/or restoring long-term memory function and performance, e.g., to improve long-term memory (LTM) and recall ability in animal subjects.
    Type: Grant
    Filed: October 31, 2001
    Date of Patent: December 7, 2004
    Assignee: Sention, Inc.
    Inventors: Mel Epstein, Kjesten A. Wiig
  • Methods for treating an impairment in memory consolidation
    Publication number: 20030232890
    Abstract: Impairments in memory consolidation are treated with an amphetamine compound. In one embodiment, the method includes administering an 1-amphetamine compound. In another embodiment, the method includes administering an 1-methamphetamine compound. The method can include determining memory consolidation before, during and/or after administering the amphetamine compound.
    Type: Application
    Filed: May 23, 2003
    Publication date: December 18, 2003
    Applicant: Sention, Inc.
    Inventors: Mel H. Epstein, Kjesten A. Wiig
  • Use of methylphenidate compounds to enhance memory
    Publication number: 20030229122
    Abstract: The present invention makes available methods and reagents for facilitating LTP, e.g., to increase memory function such as long-term memory and recall ability.
    Type: Application
    Filed: February 25, 2003
    Publication date: December 11, 2003
    Applicant: Sention, Inc.
    Inventors: Kjesten A. Wiig, Mel H. Epstein
  • Methods and compositions for regulating memory consolidation
    Publication number: 20030119884
    Abstract: The present invention makes available methods and reagents for enhancing and/or restoring long-term memory function and performance.
    Type: Application
    Filed: May 2, 2002
    Publication date: June 26, 2003
    Inventors: Mel H. Epstein, Kjesten A. Wiig
  • Use of catecholamine reuptake inhibitors to enhance memory
    Publication number: 20020161002
    Abstract: The present invention makes available methods and reagents for enhancing memory, e.g., to increase memory function such as long-term memory and recall ability.
    Type: Application
    Filed: January 2, 2002
    Publication date: October 31, 2002
    Inventors: Mel Epstein, Kjesten A. Wiig
  • Use of methylphenidate compounds to enhance memory
    Publication number: 20020132793
    Abstract: The present invention makes available methods and reagents for facilitating memory, e.g., to increase memory function such as long-term memory and recall ability. Memory is increased by increasing attention and long term consolidation.
    Type: Application
    Filed: February 28, 2002
    Publication date: September 19, 2002
    Inventors: Mel Epstein, Kjesten A. Wiig
  • Methods and compositions for regulating memory consolidation
    Publication number: 20020115725
    Abstract: The present invention makes available methods and reagents for enhancing and/or restoring long-term memory function and performance, e.g., to improve long-term memory (LTM) and recall ability in animal subjects.
    Type: Application
    Filed: October 31, 2001
    Publication date: August 22, 2002
    Inventors: Mel Epstein, Kjesten A. Wiig